Back
Ocugen Vs. SpringWorks Therapeutics Industry Stock Comparison
Sell
45
OCGN
Ocugen
Last Price:
0.98
Seasonality Move:
364.7%
Buy
60
SWTX
SpringWorks Therapeutics
Last Price:
41.74
Seasonality Move:
40.93%
Sell
45
Ocugen (OCGN)
is a Sell
Is Ocugen a Buy, Sell or Hold?
- The current Ocugen [OCGN] share price is $0.91. The Score for OCGN is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- OCGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
SpringWorks Therapeutics (SWTX)
is a Buy
Is SpringWorks Therapeutics a Buy, Sell or Hold?
- The current SpringWorks Therapeutics [SWTX] share price is $41.22. The Score for SWTX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- SWTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
OCGN Stock Price Chart
SWTX Stock Price Chart
What is SpringWorks Therapeutics's stock price today?
-
The SpringWorks Therapeutics share price today is $41.22
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
OCGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 44.9 | Sell |
| Chaikin Money Flow: | -1241898 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.9 - 1) | Sell |
| Bollinger Bands (100): | (0.91 - 1.47) | Sell |
SWTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.99 | Buy |
| Relative Strength Index (14 RSI): | 72.61 | Buy |
| Chaikin Money Flow: | 619714 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.1 - 37.18) | Buy |
| Bollinger Bands (100): | (31.78 - 39.24) | Buy |
OCGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.91 | Sell |
| 20-day SMA: | 0.96 | Sell |
| 50-day SMA: | 0.97 | Sell |
| 200-day SMA: | 1.3 | Sell |
| 8-day EMA: | 0.92 | Sell |
| 20-day EMA: | 0.94 | Sell |
| 50-day EMA: | 1.01 | Sell |
| 200-day EMA: | 1.14 | Sell |
SWTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.79 | Buy |
| 20-day SMA: | 34.7 | Buy |
| 50-day SMA: | 32.89 | Buy |
| 200-day SMA: | 39.94 | Buy |
| 8-day EMA: | 38.08 | Buy |
| 20-day EMA: | 35.64 | Buy |
| 50-day EMA: | 34.49 | Buy |
| 200-day EMA: | 36.39 | Buy |
Ocugen Earnings Growth & OCGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.07 per share.
SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.40 per share, and an increase next year of $1.22 per share.
Ocugen Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
SpringWorks Therapeutics Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||